• This record comes from PubMed

Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritins

. 1990 Nov ; 61 (5) : 278-81.

Language English Country Germany Media print

Document type Journal Article

Monoclonal antibody 2A4 against human heart ferritin and a polyclonal antibody against human placental ferritin inactivated the suppressor activity present in media conditioned by cells of patients with myelodysplastic syndrome (MDS). These antibodies also neutralized the inhibitory activity released by cells of myeloid leukemic ML-2 cell line. In contrast, a monoclonal antibody against the ferritin L subunit did not neutralize the inhibitory activity of the media conditioned either by the cells of patients with MDS or by the ML-2 cell line. Neutralization of the inhibitory activity present in supernatants of cells of MDS patients and the ML-2 cell line by monoclonal antibodies against the H subunit of ferritin strongly indicates that the inhibitory activity resides in the acidic isoferritin molecule.

See more in PubMed

Leuk Res. 1980;4(5):437-47 PubMed

Blut. 1987 Sep;55(3):165-71 PubMed

Biochim Biophys Acta. 1986 Jul 25;872(1-2):61-71 PubMed

Blood. 1986 Dec;68(6):1257-63 PubMed

Blood. 1982 Sep;60(3):595-607 PubMed

Blut. 1986 Jan;52(1):51-8 PubMed

Blood. 1986 Mar;67(3):789-95 PubMed

Blood. 1986 Feb;67(2):436-43 PubMed

J Exp Med. 1981 Jun 1;153(6):1426-44 PubMed

J Natl Cancer Inst. 1978 Mar;60(3):497-511 PubMed

Clin Chim Acta. 1983 Nov 15;134(3):347-56 PubMed

Neoplasma. 1989;36(1):83-9 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...